{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:09:53Z","timestamp":1790618993646,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,7,12]],"date-time":"2012-07-12T00:00:00Z","timestamp":1342051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.2119\/molmed.2012.00075","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T20:37:19Z","timestamp":1357245439000},"page":"1197-1208","source":"Crossref","is-referenced-by-count":36,"title":["Transformation of Epithelial Ovarian Cancer Stemlike Cells into Mesenchymal Lineage via EMT Results in Cellular Heterogeneity and Supports Tumor Engraftment"],"prefix":"10.1186","volume":"18","author":[{"given":"Hua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youji","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Janzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,12]]},"reference":[{"key":"18081197_CR1","first-page":"411","volume":"46","author":"CH Park","year":"1971","unstructured":"Park CH, Bergsagel DE, McCulloch EA. (1971) Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl. Cancer Inst. 46:411\u201322.","journal-title":"J Natl. Cancer Inst."},{"key":"18081197_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI108839","volume":"60","author":"A Hamburger","year":"1977","unstructured":"Hamburger A, Salmon SE. (1977) Primary bioassay of human myeloma stem cells. J. Clin. Invest. 60:846\u201354.","journal-title":"J. Clin. Invest."},{"key":"18081197_CR3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1126\/science.1149590","volume":"318","author":"JA Kennedy","year":"2007","unstructured":"Kennedy JA, Barabe F, Poeppl AG, Wang JC, Dick JE. (2007) Comment on \u201cTumor growth need not be driven by rare cancer stem cells.\u201d Science. 318:1722; author reply 1722.","journal-title":"Science"},{"key":"18081197_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1142596","volume":"317","author":"PN Kelly","year":"2007","unstructured":"Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. (2007) Tumor growth need not be driven by rare cancer stem cells. Science. 317:337.","journal-title":"Science"},{"key":"18081197_CR5","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:3983\u20138.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18081197_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature. 445:111\u20135.","journal-title":"Nature"},{"key":"18081197_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313\u201323.","journal-title":"Cell Stem Cell"},{"key":"18081197_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res. 67:1030\u20137.","journal-title":"Cancer Res."},{"key":"18081197_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature06489","volume":"451","author":"T Schatton","year":"2008","unstructured":"Schatton T, et al. (2008) Identification of cells initiating human melanomas. Nature. 451:345\u20139.","journal-title":"Nature"},{"key":"18081197_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/stem.791","volume":"30","author":"D Sarrio","year":"2012","unstructured":"Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM. (2012) Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell\/progenitor properties. Stem Cells. 30:292\u2013303.","journal-title":"Stem Cells"},{"key":"18081197_CR11","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","volume":"71","author":"IA Silva","year":"2011","unstructured":"Silva IA, et al. (2011) Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 71:3991\u20134001.","journal-title":"Cancer Res."},{"key":"18081197_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1634\/stemcells.2005-0282","volume":"24","author":"N Haraguchi","year":"2006","unstructured":"Haraguchi N, et al. (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24:506\u201313.","journal-title":"Stem Cells"},{"key":"18081197_CR13","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax C, et al. (2004) A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U. S. A. 101:14228\u201333.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18081197_CR14","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, et al. (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc. Natl. Acad. Sci. U. S. A. 103:11154\u20139.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18081197_CR15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrd2137","volume":"8","author":"BB Zhou","year":"2009","unstructured":"Zhou BB, et al. (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug. Discov. 8:806\u201323.","journal-title":"Nat. Rev. Drug. Discov."},{"key":"18081197_CR16","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. (2010) Ovarian cancer development and metastasis. Am. J. Pathol. 177:1053\u201364.","journal-title":"Am. J. Pathol."},{"key":"18081197_CR17","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/cncr.20946","volume":"103","author":"S Elloul","year":"2005","unstructured":"Elloul S, et al. (2005) Snail, Slug, and Smadinteracting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 103:1631\u201343.","journal-title":"Cancer"},{"key":"18081197_CR18","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/ijc.24901","volume":"126","author":"H Jin","year":"2010","unstructured":"Jin H, et al. (2010) Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int. J. Cancer. 126:2102\u201311.","journal-title":"Int. J. Cancer"},{"key":"18081197_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jcp.21240","volume":"213","author":"N Ahmed","year":"2007","unstructured":"Ahmed N, Thompson EW, Quinn MA. (2007) Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J. Cell Physiol. 213:581\u20138.","journal-title":"J. Cell Physiol."},{"key":"18081197_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1434.009","volume":"1127","author":"O Oktem","year":"2008","unstructured":"Oktem O, Oktay K. (2008) The ovary: anatomy and function throughout human life. Ann. N. Y. Acad. Sci. 1127:1\u20139.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"18081197_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","volume":"9","author":"L Dubeau","year":"2008","unstructured":"Dubeau L. (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol 9:1191\u20137.","journal-title":"Lancet Oncol"},{"key":"18081197_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","volume":"198","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih Ie M. (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am. J. Obstet. Gynecol. 198:351\u20136.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"18081197_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704\u201315.","journal-title":"Cell"},{"key":"18081197_CR24","first-page":"233","volume":"18","author":"X Shenhua","year":"1999","unstructured":"Shenhua X, et al. (1999) Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. J. Exp. Clin. Cancer Res. 18:233\u20139.","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"18081197_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","volume":"183","author":"MA Goodell","year":"1996","unstructured":"Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797\u2013806.","journal-title":"J. Exp. Med."},{"key":"18081197_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0092-8674(03)00234-4","volume":"113","author":"N Fujita","year":"2003","unstructured":"Fujita N, et al. (2003) MTA3, a Mi-2\/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 113:207\u201319.","journal-title":"Cell"},{"key":"18081197_CR27","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources","year":"1996","unstructured":"Institute of Laboratory Animal Resources; Commission on Life Sciences; National Research Council. (1996) Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academy Press. [cited 2012 Oct. 2]. Available from: https:\/\/doi.org\/www.nap.edu\/openbook.php?record_id=5140"},{"key":"18081197_CR28","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1158\/0008-5472.CAN-07-6341","volume":"68","author":"L Moserle","year":"2008","unstructured":"Moserle L, et al. (2008) The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res. 68:5658\u201368.","journal-title":"Cancer Res."},{"key":"18081197_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13577-010-0002-z","volume":"24","author":"S Hosonuma","year":"2011","unstructured":"Hosonuma S, et al. (2011) Clinical significance of side population in ovarian cancer cells. Hum. Cell. 24:9\u201312.","journal-title":"Hum. Cell"},{"key":"18081197_CR30","doi-asserted-by":"publisher","first-page":"e16186","DOI":"10.1371\/journal.pone.0016186","volume":"6","author":"R Strauss","year":"2011","unstructured":"Strauss R, et al. (2011) Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One. 6: e16186.","journal-title":"PLoS One"},{"key":"18081197_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2009.02.034","volume":"284","author":"P Jiang","year":"2009","unstructured":"Jiang P, Enomoto A, Takahashi M. (2009) Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. 284:122\u201330.","journal-title":"Cancer Lett."},{"key":"18081197_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2353\/ajpath.2010.090056","volume":"176","author":"K Kato","year":"2010","unstructured":"Kato K, et al. (2010) Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am. J. Pathol. 176:381\u201392.","journal-title":"Am. J. Pathol."},{"key":"18081197_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4149\/neo_2009_05_371","volume":"56","author":"YH Wang","year":"2009","unstructured":"Wang YH, et al. (2009) A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma. 56:371\u20138.","journal-title":"Neoplasma"},{"key":"18081197_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","volume":"4","author":"AM Bleau","year":"2009","unstructured":"Bleau AM, etal. (2009) PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 4:226\u201335.","journal-title":"Cell Stem Cell."},{"key":"18081197_CR35","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1158\/0008-5472.CAN-08-0786","volume":"68","author":"MA Harris","year":"2008","unstructured":"Harris MA, et al. (2008) Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 68:10051\u20139.","journal-title":"Cancer Res."},{"key":"18081197_CR36","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1158\/0008-5472.CAN-07-0999","volume":"67","author":"C Wu","year":"2007","unstructured":"Wu C, et al. (2007) Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 67:8216\u201322.","journal-title":"Cancer Res."},{"key":"18081197_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ygyno.2004.02.032","volume":"94","author":"PJ Stiff","year":"2004","unstructured":"Stiff PJ, et al. (2004) Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study. Gynecol. Oncol. 94:98\u2013106.","journal-title":"Gynecol. Oncol."},{"key":"18081197_CR38","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/onc.2010.509","volume":"30","author":"K Vuoriluoto","year":"2011","unstructured":"Vuoriluoto K, et al. (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 30:1436\u201348.","journal-title":"Oncogene"},{"key":"18081197_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua D, et al. (2008) TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 133:66\u201377.","journal-title":"Cell"},{"key":"18081197_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1074\/jbc.M804777200","volume":"284","author":"K Horiguchi","year":"2009","unstructured":"Horiguchi K, et al. (2009) Role of Ras signaling in the induction of snail by transforming growth factor-beta. J. Biol. Chem. 284:245\u201353.","journal-title":"J. Biol. Chem."},{"key":"18081197_CR41","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/onc.2010.546","volume":"30","author":"S Ehata","year":"2011","unstructured":"Ehata S, et al. (2011) Transforming growth factor-beta decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene. 30:1693\u2013705.","journal-title":"Oncogene"},{"key":"18081197_CR42","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-06-2926","volume":"13","author":"B Hotz","year":"2007","unstructured":"Hotz B, et al. (2007) Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin. Cancer Res. 13:4769\u201376.","journal-title":"Clin. Cancer Res."},{"key":"18081197_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/dvdy.20345","volume":"233","author":"ED Hay","year":"2005","unstructured":"Hay ED. (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 233:706\u201320.","journal-title":"Dev. Dyn."},{"key":"18081197_CR44","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 29:4741\u201351.","journal-title":"Oncogene"},{"key":"18081197_CR45","doi-asserted-by":"publisher","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"AP Morel","year":"2008","unstructured":"Morel AP, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 3:e2888.","journal-title":"PLoS One"},{"key":"18081197_CR46","doi-asserted-by":"publisher","first-page":"932371","DOI":"10.1155\/2010\/932371","volume":"2010","author":"AM Karst","year":"2010","unstructured":"Karst AM, Drapkin R. (2010) Ovarian cancer pathogenesis: a model in evolution. J. Oncol. 2010:932371.","journal-title":"J. Oncol."},{"key":"18081197_CR47","doi-asserted-by":"publisher","first-page":"105269","DOI":"10.1155\/2010\/105269","volume":"2010","author":"S Dyall","year":"2010","unstructured":"Dyall S, Gayther SA, Dafou D. (2010) Cancer stem cells and epithelial ovarian cancer. J. Oncol. 2010:105269.","journal-title":"J. Oncol."},{"key":"18081197_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/onc.2008.374","volume":"28","author":"T Baba","year":"2009","unstructured":"Baba T, et al. (2009) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. 28:209\u201318.","journal-title":"Oncogene"},{"key":"18081197_CR49","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, et al. (2009) CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 27:2875\u201383.","journal-title":"Stem Cells"},{"key":"18081197_CR50","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, et al. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68:4311\u201320.","journal-title":"Cancer Res."},{"key":"18081197_CR51","doi-asserted-by":"publisher","first-page":"18874","DOI":"10.1073\/pnas.1012667107","volume":"107","author":"X Wei","year":"2010","unstructured":"Wei X, et al. (2010) Mullerian inhibiting substance preferentially inhibits stem\/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc. Natl. Acad. Sci. U. S. A. 107:18874\u20139.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18081197_CR52","doi-asserted-by":"publisher","first-page":"e15689","DOI":"10.1371\/journal.pone.0015689","volume":"5","author":"R Peters","year":"2010","unstructured":"Peters R, et al. (2010) Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture. PLoS One. 5:e15689.","journal-title":"PLoS One"},{"key":"18081197_CR53","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.exphem.2006.03.007","volume":"34","author":"S Pozzi","year":"2006","unstructured":"Pozzi S, et al. (2006) Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Exp. Hematol. 34:934\u201342.","journal-title":"Exp. Hematol."},{"key":"18081197_CR54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijc.2910580315","volume":"58","author":"AL Veatch","year":"1994","unstructured":"Veatch AL, Carson LF, Ramakrishnan S. (1994) Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer. 58:393\u20139.","journal-title":"Int. J. Cancer."},{"key":"18081197_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/1078-0432.CCR-08-1233","volume":"15","author":"E Katz","year":"2009","unstructured":"Katz E, Skorecki K, Tzukerman M. (2009) Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations. Clin. Cancer Res. 15:70\u201380.","journal-title":"Clin. Cancer Res."},{"key":"18081197_CR56","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","volume":"65","author":"SA Bapat","year":"2005","unstructured":"Bapat SA, Mali AM, Koppikar CB, Kurrey NK. (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65:3025\u20139.","journal-title":"Cancer Res."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2012.00075\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2012.00075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T07:18:49Z","timestamp":1714807129000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2012.00075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,12]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["18081197"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2012.00075","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,12]]}}}